benzo[b]fluoranthene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	benzo[b]fluoranthene	go back to main search page
Accession:	CHEBI:34565	browse the term
Definition:	An ortho- and peri-fused polycyclic arene that consists of a benzene ring fused with a acephenanthrylene ring.
Synonyms:	exact_synonym:	benzo[e]acephenanthrylene
	related_synonym:	2,3-Benzfluoranthene; 2,3-Benzofluoranthene; 3,4-Benzfluoranthene; B(b)F; BF; Formula=C20H12; InChI=1S/C20H12/c1-2-7-14-13(6-1)12-19-16-9-4-3-8-15(16)18-11-5-10-17(14)20(18)19/h1-12H; InChIKey=FTOVXSOBNPWTSH-UHFFFAOYSA-N; SMILES=c1ccc-2c(c1)-c1cccc3c4ccccc4cc-2c13
	xref:	Beilstein:1872553; CAS:205-99-2; KEGG:C14320
	xref_mesh:	MESH:C006703
	xref:	PMID:18830893; Reaxys:1872553; Wikipedia:Benzo(b)fluoranthene

show annotations for term's descendants Sort by:
Rat (1532) Mouse (1653) Human (1563) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1532)

benzo[b]fluoranthene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aladin WD repeat nucleoporin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AAAS mRNA

NCBI chr 7:133,464,315...133,483,961
Ensembl chr 7:133,464,315...133,483,961

G

aminoadipate-semialdehyde synthase

decreases expression

benzo(b)fluoranthene results in decreased expression of AASS mRNA

NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136

G

apoptosis-associated tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of AATK mRNA

NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112

G

ATP binding cassette subfamily A member 1

increases expression

benzo(b)fluoranthene results in increased expression of ABCA1 mRNA

NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170

G

ATP binding cassette subfamily A member 7

increases expression

benzo(b)fluoranthene results in increased expression of ABCA7 mRNA

NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425

G

ATP binding cassette subfamily A member 8

increases expression

benzo(b)fluoranthene results in increased expression of ABCA8B mRNA

NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988

G

ATP binding cassette subfamily B member 1A

increases expression

benzo(b)fluoranthene results in increased expression of ABCB1A mRNA

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP-binding cassette, sub-family B member 1B

increases expression

benzo(b)fluoranthene results in increased expression of ABCB1B mRNA

NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199

G

ATP binding cassette subfamily B member 4

increases expression

benzo(b)fluoranthene results in increased expression of ABCB4 mRNA

NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202

G

ATP binding cassette subfamily C member 5

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ABCC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABCC5 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253

G

ATP binding cassette subfamily G member 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ABCG2 mRNA

NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409

G

ATP binding cassette subfamily G member 4

decreases expression

benzo(b)fluoranthene results in decreased expression of ABCG4 mRNA

NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881

G

abhydrolase domain containing 14b

decreases expression

benzo(b)fluoranthene results in decreased expression of ABHD14B mRNA

NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119

G

ABI family, member 3

increases expression

benzo(b)fluoranthene results in increased expression of ABI3 mRNA

NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816

G

ABI family member 3 binding protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA

NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929

G

actin-binding LIM protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ABLIM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ABLIM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969

G

abraxas 2, BRISC complex subunit

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABRAXAS2 mRNA

NCBI chr 1:187,647,078...187,672,660
Ensembl chr 1:187,647,067...187,672,655

G

acetyl-CoA carboxylase alpha

increases expression

benzo(b)fluoranthene results in increased expression of ACACA mRNA

NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 3

increases expression

benzo(b)fluoranthene results in increased expression of ACAP3 mRNA

NCBI chr 5:166,501,150...166,515,477
Ensembl chr 5:166,500,781...166,515,481

G

apoptotic chromatin condensation inducer 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACIN1 mRNA

NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001

G

atypical chemokine receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of ACKR2 mRNA

NCBI chr 8:121,559,563...121,573,633
Ensembl chr 8:121,561,211...121,573,582

G

atypical chemokine receptor 4

decreases expression

benzo(b)fluoranthene results in decreased expression of ACKR4 mRNA

NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617

G

acyl-CoA thioesterase 1

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOT1 mRNA
benzo(b)fluoranthene results in decreased expression of ACOT1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA oxidase-like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOXL mRNA

NCBI chr 3:115,061,069...115,367,032
Ensembl chr 3:115,061,060...115,364,686

G

adenosine deaminase

increases expression

benzo(b)fluoranthene results in increased expression of ADA mRNA

NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088

G

ADAM metallopeptidase domain 15

increases expression

benzo(b)fluoranthene results in increased expression of ADAM15 mRNA

NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113

G

ADAM-like, decysin 1

increases expression

benzo(b)fluoranthene results in increased expression of ADAMDEC1 mRNA

NCBI chr15:42,900,629...42,921,684
Ensembl chr15:42,900,636...42,921,712

G

ADAM metallopeptidase with thrombospondin type 1 motif, 14

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ADAMTS14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADAMTS14 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866

G

ADAM metallopeptidase with thrombospondin type 1 motif, 15

decreases expression

benzo(b)fluoranthene results in decreased expression of ADAMTS15 mRNA

NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

increases expression

benzo(b)fluoranthene results in increased expression of ADAMTS4 mRNA

NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065

G

ADAMTS-like 2

increases expression

benzo(b)fluoranthene results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554

G

adenylate cyclase 4

increases expression

benzo(b)fluoranthene results in increased expression of ADCY4 mRNA

NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108

G

adenylate cyclase 5

increases expression

benzo(b)fluoranthene results in increased expression of ADCY5 mRNA

NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974

G

ADCYAP receptor type I

increases expression

benzo(b)fluoranthene results in increased expression of ADCYAP1R1 mRNA

NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700

G

adducin 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ADD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124

G

adhesion G protein-coupled receptor A3

increases expression

benzo(b)fluoranthene results in increased expression of ADGRA3 mRNA

NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332

G

adhesion G protein-coupled receptor E4

decreases expression

benzo(b)fluoranthene results in decreased expression of ADGRE4 mRNA

NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760

G

adhesion G protein-coupled receptor F1

increases expression

benzo(b)fluoranthene results in increased expression of ADGRF1 mRNA

NCBI chr 9:17,661,258...17,696,359
Ensembl chr 9:17,660,930...17,711,704

G

adhesion G protein-coupled receptor F5

increases expression

benzo(b)fluoranthene results in increased expression of ADGRF5 mRNA

NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968

G

adhesion G protein-coupled receptor G3

increases expression

benzo(b)fluoranthene results in increased expression of ADGRG3 mRNA

NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123

G

adhesion G protein-coupled receptor L1

increases expression

benzo(b)fluoranthene results in increased expression of ADGRL1 mRNA

NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139

G

adhesion G protein-coupled receptor L2

increases expression

benzo(b)fluoranthene results in increased expression of ADGRL2 mRNA

NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:237,696,056...238,327,141

G

adhesion G protein-coupled receptor L4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ADGRL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADGRL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225

G

adhesion G protein-coupled receptor V1

decreases expression

benzo(b)fluoranthene results in decreased expression of ADGRV1 mRNA

NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688

G

alcohol dehydrogenase 4 (class II), pi polypeptide

decreases expression

benzo(b)fluoranthene results in decreased expression of ADH4 mRNA

NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591

G

adipogenin

decreases expression

benzo(b)fluoranthene results in decreased expression of ADIG mRNA

NCBI chr 3:147,155,079...147,160,412
Ensembl chr 3:147,154,097...147,160,490
Ensembl chr 3:147,154,097...147,160,490

G

adiponectin, C1Q and collagen domain containing

decreases expression

benzo(b)fluoranthene results in decreased expression of ADIPOQ mRNA

NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564

G

adrenomedullin

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ADM mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADM mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

adenosine A3 receptor

increases expression

benzo(b)fluoranthene results in increased expression of ADORA3 mRNA

NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357

G

adrenoceptor beta 3

increases expression

benzo(b)fluoranthene results in increased expression of ADRB3 mRNA

NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552

G

apoptosis enhancing nuclease

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of AEN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523

G

AGBL carboxypeptidase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA

NCBI chr 3:76,764,893...76,800,071
Ensembl chr 3:76,764,238...76,800,214

G

argonaute RISC catalytic component 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA

NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974

G

1-acylglycerol-3-phosphate O-acyltransferase 2

decreases expression

benzo(b)fluoranthene results in decreased expression of AGPAT2 mRNA

NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371

G

adenosylhomocysteinase

decreases expression

benzo(b)fluoranthene results in decreased expression of AHCY mRNA

NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393

G

adenosylhomocysteinase-like 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AHCYL2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHCYL2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060

G

AHNAK nucleoprotein

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AHNAK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHNAK mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926

G

aryl hydrocarbon receptor

multiple interactions
affects response to substance
increases expression
increases response to substance
increases activity

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CCNA2 protein]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; benzo(b)fluoranthene binds to and results in increased activity of AHR protein
AHR affects the susceptibility to benzo(b)fluoranthene
benzo(b)fluoranthene results in increased expression of AHR protein
AHR results in increased susceptibility to benzo(b)fluoranthene
benzo(b)fluoranthene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]
benzo(b)fluoranthene results in increased activity of AHR protein

PMID:11525907 PMID:12117779 PMID:12371477 PMID:12850102 PMID:17141280 More...

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

aryl-hydrocarbon receptor repressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of AHRR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AHRR mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673

G

allograft inflammatory factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AIF1 mRNA

NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668

G

apoptosis inducing factor, mitochondria associated 3

increases expression

benzo(b)fluoranthene results in increased expression of AIFM3 mRNA

NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248

G

adenylate kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of AK1 mRNA

NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041

G

A-kinase anchoring protein 7

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AKAP7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797

G

aldo-keto reductase family 1 member B1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of AKR1B1 mRNA

NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157

G

aldo-keto reductase family 1, member C1

increases expression

benzo(b)fluoranthene results in increased expression of AKR1C1 mRNA

NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326

G

5'-aminolevulinate synthase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ALAS1 mRNA

NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917

G

5'-aminolevulinate synthase 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ALAS2 mRNA

NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519

G

aldehyde dehydrogenase 1 family, member A1

decreases expression

benzo(b)fluoranthene results in decreased expression of ALDH1A1 mRNA

NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961

G

aldolase, fructose-bisphosphate B

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ALDOB mRNA

NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116

G

alkB homolog 7

decreases expression

benzo(b)fluoranthene results in decreased expression of ALKBH7 mRNA

NCBI chr 9:1,838,886...1,841,044
Ensembl chr 9:1,838,811...1,841,044

G

arachidonate 5-lipoxygenase

increases expression

benzo(b)fluoranthene results in increased expression of ALOX5 mRNA

NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743

G

angiomotin

increases expression

benzo(b)fluoranthene results in increased expression of AMOT mRNA

NCBI chr X:108,982,399...109,041,265
Ensembl chr X:108,984,022...109,041,272

G

anaphase promoting complex subunit 11

increases expression

benzo(b)fluoranthene results in increased expression of ANAPC11 mRNA

NCBI chr10:105,875,209...105,886,307

G

angiopoietin-like 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ANGPTL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANGPTL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519

G

ankyrin 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA

NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300

G

ankyrin repeat domain 12

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANKRD12 mRNA

NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911

G

ankyrin repeat domain 29

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD29 mRNA

NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296

G

ankyrin repeat domain 44

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD44 mRNA

NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508

G

ankyrin repeat domain 63

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD63 mRNA

NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404

G

anillin, actin binding protein

increases expression

benzo(b)fluoranthene results in increased expression of ANLN mRNA

NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538

G

acidic nuclear phosphoprotein 32 family member A

affects expression

benzo(b)fluoranthene affects the expression of ANP32A mRNA

NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443

G

alanyl aminopeptidase, membrane

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANPEP mRNA

NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789

G

annexin A7

increases expression

benzo(b)fluoranthene results in increased expression of ANXA7 mRNA

NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385

G

aldehyde oxidase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of AOX1 mRNA

NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770

G

adaptor related protein complex 4 subunit beta 1

increases expression

benzo(b)fluoranthene results in increased expression of AP4B1 mRNA

NCBI chr 2:191,318,485...191,330,531
Ensembl chr 2:191,318,482...191,330,531

G

APC down-regulated 1

increases expression

benzo(b)fluoranthene results in increased expression of APCDD1 mRNA

NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070

G

apelin

decreases expression

benzo(b)fluoranthene results in decreased expression of APLN mRNA

NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391

G

apelin receptor

decreases expression

benzo(b)fluoranthene results in decreased expression of APLNR mRNA

NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050

G

apolipoprotein C3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of APOC3 mRNA

NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583

G

apolipoprotein L9a

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649

G

androgen receptor

increases activity

benzo(b)fluoranthene results in increased activity of AR protein

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

amphiregulin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AREG mRNA

NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535

G

ADP-ribosylation factor GTPase activating protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ARFGAP1 mRNA

NCBI chr 3:168,084,560...168,099,948
Ensembl chr 3:168,084,614...168,099,933

G

arginine and glutamate rich 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARGLU1 mRNA

NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349

G

Rho GTPase activating protein 17

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP17 mRNA

NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854

G

Rho GTPase activating protein 20

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP20 mRNA

NCBI chr 8:52,074,472...52,155,739
Ensembl chr 8:52,074,158...52,155,739

G

Rho GTPase activating protein 22

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP22 mRNA

NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548

G

Rho GTPase activating protein 23

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP23 mRNA

NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504

G

Rho GTPase activating protein 40

increases expression

benzo(b)fluoranthene results in increased expression of ARHGAP40 mRNA

NCBI chr 3:147,165,781...147,206,552
Ensembl chr 3:147,165,729...147,207,203

G

Rho guanine nucleotide exchange factor 15

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGEF15 mRNA

NCBI chr10:53,650,521...53,663,269
Ensembl chr10:53,650,553...53,663,913

G

Rho guanine nucleotide exchange factor 16

increases expression

benzo(b)fluoranthene results in increased expression of ARHGEF16 mRNA

NCBI chr 5:164,843,656...164,866,212
Ensembl chr 5:164,844,161...164,866,212

G

Rho guanine nucleotide exchange factor 3

increases expression

benzo(b)fluoranthene results in increased expression of ARHGEF3 mRNA

NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945

G

Rho guanine nucleotide exchange factor 38

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:221,613,070...221,740,079

G

Rho guanine nucleotide exchange factor 40

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ARHGEF40 mRNA

NCBI chr15:24,672,645...24,696,510
Ensembl chr15:24,672,763...24,696,510

G

armadillo repeat containing 6

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARMC6 mRNA

NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047

G

arrestin domain containing 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ARRDC4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARRDC4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290

G

arylsulfatase family, member J

decreases expression

benzo(b)fluoranthene results in decreased expression of ARSJ mRNA

NCBI chr 2:214,774,631...214,854,614
Ensembl chr 2:214,774,654...214,854,612

G

ankyrin repeat and SOCS box-containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ASB2 mRNA

NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854

G

activating signal cointegrator 1 complex subunit 3

decreases expression

benzo(b)fluoranthene results in decreased expression of ASCC3 mRNA

NCBI chr20:53,510,137...53,795,446
Ensembl chr20:53,510,184...53,790,165

G

anti-silencing function 1B histone chaperone

increases expression

benzo(b)fluoranthene results in increased expression of ASF1B mRNA

NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549

G

asialoglycoprotein receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ASGR1 mRNA

NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631

G

asialoglycoprotein receptor 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ASGR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASGR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617

G

argininosuccinate lyase

decreases expression

benzo(b)fluoranthene results in decreased expression of ASL mRNA

NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662

G

aspartoacylase

increases expression

benzo(b)fluoranthene results in increased expression of ASPA mRNA

NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272

G

asparaginase

increases expression

benzo(b)fluoranthene results in increased expression of ASPG mRNA

NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268

G

aspartate-beta-hydroxylase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASPH mRNA

NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876

G

assembly factor for spindle microtubules

increases expression

benzo(b)fluoranthene results in increased expression of ASPM mRNA

NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755

G

argininosuccinate synthase 1

increases expression

benzo(b)fluoranthene results in increased expression of ASS1 mRNA

NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903

G

ATPase family, AAA domain containing 2B

decreases expression

benzo(b)fluoranthene results in decreased expression of ATAD2B mRNA

NCBI chr 6:27,914,546...28,070,103
Ensembl chr 6:27,912,862...28,067,047

G

activating transcription factor 3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

atonal bHLH transcription factor 8

decreases expression

benzo(b)fluoranthene results in decreased expression of ATOH8 mRNA

NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168

G

atos homolog A

increases expression

benzo(b)fluoranthene results in increased expression of ATOSA mRNA

NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549

G

atos homolog B

increases expression

benzo(b)fluoranthene results in increased expression of ATOSB mRNA

NCBI chr 5:57,260,839...57,274,524
Ensembl chr 5:57,260,841...57,268,892

G

ATPase 13A3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP13A3 mRNA

NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ATP2A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101

G

ATPase, class I, type 8B, member 5

increases expression

benzo(b)fluoranthene results in increased expression of ATP8B5 mRNA

NCBI chr 5:57,505,897...57,620,065
Ensembl chr 5:57,506,466...57,620,056

G

aurora kinase A and ninein interacting protein

increases expression

benzo(b)fluoranthene results in increased expression of AUNIP mRNA

NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501

G

aurora kinase A

increases expression

benzo(b)fluoranthene results in increased expression of AURKA mRNA

NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390

G

AVL9 cell migration associated

increases expression

benzo(b)fluoranthene results in increased expression of AVL9 mRNA

NCBI chr 4:85,961,493...86,008,347
Ensembl chr 4:85,961,635...86,008,791

G

arginine vasopressin-induced 1

increases expression

benzo(b)fluoranthene results in increased expression of AVPI1 mRNA

NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

increases expression

benzo(b)fluoranthene results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166

G

beta-1,4-galactosyltransferase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA

NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461

G

beta-1,4-galactosyltransferase 5

increases expression

benzo(b)fluoranthene results in increased expression of B4GALT5 mRNA

NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074

G

beta-secretase 2

increases expression

benzo(b)fluoranthene results in increased expression of BACE2 mRNA

NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546

G

BCL2-associated agonist of cell death

increases expression

benzo(b)fluoranthene results in increased expression of BAD protein

NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823

G

B-cell scaffold protein with ankyrin repeats 1

increases expression

benzo(b)fluoranthene results in increased expression of BANK1 mRNA

NCBI chr 2:224,530,475...224,800,420
Ensembl chr 2:224,530,475...224,800,405

G

BRCA1 associated RING domain 1

increases expression

benzo(b)fluoranthene results in increased expression of BARD1 mRNA

NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265

G

basic leucine zipper ATF-like transcription factor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA

NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051

G

basic leucine zipper ATF-like transcription factor 2

increases expression

benzo(b)fluoranthene results in increased expression of BATF2 mRNA

NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889

G

BCL2 associated X, apoptosis regulator

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BAX mRNA; benzo(b)fluoranthene results in increased expression of BAX protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BAX mRNA

PMID:21392559 PMID:26377693 PMID:27858113

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

butyrylcholinesterase

increases expression

benzo(b)fluoranthene results in increased expression of BCHE mRNA

NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148

G

BCL2, apoptosis regulator

increases expression

benzo(b)fluoranthene results in increased expression of BCL2 protein

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

increases expression

benzo(b)fluoranthene results in increased expression of BCL2L1 protein

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

Bcl2-like 11

increases expression

benzo(b)fluoranthene results in increased expression of BCL2L11 protein

NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068

G

BCL3, transcription coactivator

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA

NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607

G

BCL6B, transcription repressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BCL6B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BCL6B mRNA

PMID:26377693 PMID:27858113

NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974

G

BAF chromatin remodeling complex subunit BCL7B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA

NCBI chr12:21,496,860...21,510,079
Ensembl chr12:21,496,856...21,510,202

G

brain expressed, associated with NEDD4, 1

increases expression

benzo(b)fluoranthene results in increased expression of BEAN1 mRNA

NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537

G

brain expressed X-linked 1

increases expression

benzo(b)fluoranthene results in increased expression of BEX2 mRNA

NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958

G

beaded filament structural protein 1

increases expression

benzo(b)fluoranthene results in increased expression of BFSP1 mRNA

NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337

G

beaded filament structural protein 2

increases expression

benzo(b)fluoranthene results in increased expression of BFSP2 mRNA

NCBI chr 8:104,006,226...104,063,399
Ensembl chr 8:104,006,226...104,063,399

G

basic helix-loop-helix family, member e40

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BHLHE40 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774

G

betaine-homocysteine S-methyltransferase

decreases expression

benzo(b)fluoranthene results in decreased expression of BHMT mRNA

NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742

G

bridging integrator 1

increases expression

benzo(b)fluoranthene results in increased expression of BIN1 mRNA

NCBI chr18:24,009,731...24,067,267
Ensembl chr18:24,009,653...24,067,263

G

baculoviral IAP repeat-containing 5

multiple interactions
increases expression

benzo(b)fluoranthene affects the localization of and results in increased expression of BIRC5 protein
benzo(b)fluoranthene results in increased expression of BIRC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA

PMID:21776270 PMID:26377693 PMID:27858113

NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380

G

biogenesis of lysosomal organelles complex-1, subunit 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA

NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653

G

biogenesis of lysosomal organelles complex 1 subunit 6

increases expression

benzo(b)fluoranthene results in increased expression of BLOC1S6 mRNA

NCBI chr 3:109,816,397...109,826,528
Ensembl chr 3:109,816,366...109,828,308

G

basic helix-loop-helix ARNT like 1

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA
benzo(b)fluoranthene results in decreased expression of BMAL1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of BMP6 mRNA

NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365

G

bone morphogenetic protein receptor type 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of BMPR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809

G

BMP/retinoic acid inducible neural specific 1

increases expression

benzo(b)fluoranthene results in increased expression of BRINP1 mRNA

NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150

G

bromodomain and WD repeat domain containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of BRWD1 mRNA

NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768

G

BSCL2 lipid droplet biogenesis associated, seipin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BSCL2 mRNA

NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421

G

bone marrow stromal cell antigen 1

increases expression

benzo(b)fluoranthene results in increased expression of BST1 mRNA

NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180

G

B and T lymphocyte associated

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BTLA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA

PMID:26377693 PMID:27858113

NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181

G

butyrophilin-like 9

increases expression

benzo(b)fluoranthene results in increased expression of BTNL9 mRNA

NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025

G

blood vessel epicardial substance

decreases expression

benzo(b)fluoranthene results in decreased expression of POPDC1 mRNA

NCBI chr20:48,819,241...48,860,282
Ensembl chr20:48,822,308...48,857,472

G

C1q and TNF related 5

increases expression

benzo(b)fluoranthene results in increased expression of C1QTNF5 mRNA

NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074

G

complement C1s

increases expression

benzo(b)fluoranthene results in increased expression of C1S mRNA

NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303

G

C2 domain containing 3 centriole elongation regulator

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of C2CD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C2CD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:154,715,151...154,812,955
Ensembl chr 1:154,715,310...154,812,520

G

complement C3

increases expression

benzo(b)fluoranthene results in increased expression of C3 mRNA

NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429

G

complement C4B

increases expression

benzo(b)fluoranthene results in increased expression of C4B mRNA

NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681

G

complement C5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HC mRNA

NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994

G

complement C5a receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA

NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517

G

complement C7

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C7 mRNA

NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535

G

Cdk5 and Abl enzyme substrate 1

increases expression

benzo(b)fluoranthene results in increased expression of CABLES1 mRNA

NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181

G

calcium binding protein 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CABP5 mRNA

NCBI chr 1:74,350,811...74,363,830
Ensembl chr 1:74,350,811...74,363,830

G

calcitonin receptor

increases expression

benzo(b)fluoranthene results in increased expression of CALCR mRNA

NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392

G

calcium/calmodulin-dependent protein kinase II gamma

increases expression

benzo(b)fluoranthene results in increased expression of CAMK2G mRNA

NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050

G

calpain 5

increases expression

benzo(b)fluoranthene results in increased expression of CAPN5 mRNA

NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923

G

carbonic anhydrase 14

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CAR14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAR14 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693

G

carbonic anhydrase 2

increases expression

benzo(b)fluoranthene results in increased expression of CAR2 mRNA

NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818

G

carbonic anhydrase 3

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CA3 mRNA
benzo(b)fluoranthene results in decreased expression of CAR3 mRNA

PMID:17690111 PMID:26377693

NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280

G

carbonic anhydrase 8

increases expression

benzo(b)fluoranthene results in increased expression of CAR8 mRNA

NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374

G

caspase recruitment domain family, member 19

increases expression

benzo(b)fluoranthene results in increased expression of CARD19 mRNA

NCBI chr17:15,432,632...15,445,317
Ensembl chr17:15,432,612...15,445,318

G

calcium regulated heat stable protein 1

increases expression

benzo(b)fluoranthene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

castor zinc finger 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CASZ1 mRNA

NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400

G

caveolin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA

NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705

G

caveolin 3

increases expression

benzo(b)fluoranthene results in increased expression of CAV3 mRNA

NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137

G

CBFA2/RUNX1 partner transcriptional co-repressor 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CBFA2T3 mRNA

NCBI chr19:50,679,897...50,750,028
Ensembl chr19:50,680,729...50,749,610

G

collagen and calcium binding EGF domains 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCBE1 mRNA

NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400

G

coiled-coil domain containing 122

increases expression

benzo(b)fluoranthene results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:52,407,717...52,470,163

G

coiled-coil domain containing 184

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCDC184 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCDC184 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:129,297,635...129,301,961
Ensembl chr 7:129,298,212...129,304,494

G

coiled-coil domain containing 30

decreases expression

benzo(b)fluoranthene results in decreased expression of CCDC30 mRNA

NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659

G

coiled-coil domain containing 68

increases expression

benzo(b)fluoranthene results in increased expression of CCDC68 mRNA

NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119

G

C-C motif chemokine ligand 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231

G

C-C motif chemokine ligand 5

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCL5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377

G

C-C motif chemokine ligand 9

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA

NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369

G

CCM2 like scaffold protein

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCM2L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140

G

cellular communication network factor 1

increases expression

benzo(b)fluoranthene results in increased expression of CCN1 mRNA

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 4

increases expression

benzo(b)fluoranthene results in increased expression of CCN4 mRNA

NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248

G

cyclin A2

multiple interactions
increases expression
decreases expression

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CCNA2 protein]; benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]
benzo(b)fluoranthene results in decreased expression of CCNA2 mRNA
benzo(b)fluoranthene results in increased expression of CCNA2 mRNA

PMID:16269432 PMID:17141280 PMID:26377693

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

increases expression

benzo(b)fluoranthene results in increased expression of CCNB1 mRNA

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

cyclin B2

increases expression

benzo(b)fluoranthene results in increased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin D1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCND1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602

G

cyclin D2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCND2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495

G

cyclin D3

increases expression

benzo(b)fluoranthene results in increased expression of CCND3 mRNA

NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371

G

cyclin F

increases expression

benzo(b)fluoranthene results in increased expression of CCNF mRNA

NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101

G

cyclin G1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCNG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCNG1 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641

G

cyclin J-like

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCNJL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNJL mRNA

PMID:26377693 PMID:27858113

NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426

G

cyclin L1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNL1 mRNA

NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368

G

cyclin L2

increases expression

benzo(b)fluoranthene results in increased expression of CCNL2 mRNA

NCBI chr 5:166,416,940...166,428,997
Ensembl chr 5:166,417,508...166,436,882

G

cyclin O

increases expression

benzo(b)fluoranthene results in increased expression of CCNO mRNA

NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914

G

C-C motif chemokine receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CCR2 mRNA

NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100

G

C-C motif chemokine receptor 7

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCR7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCR7 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309

G

CD151 molecule (Raph blood group)

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD151 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD151 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753

G

CD164 molecule like 2

increases expression

benzo(b)fluoranthene results in increased expression of CD164L2 mRNA

NCBI chr 5:145,414,805...145,427,747
Ensembl chr 5:145,423,892...145,427,720

G

CD19 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD19 mRNA

NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975

G

CD1d1 molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD1D1 mRNA

NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089

G

Cd200 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD200 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD200 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648

G

CD209d molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD209D mRNA

NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171

G

CD226 molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD226 mRNA

NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051

G

Cd300e molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD300E mRNA

NCBI chr10:100,289,729...100,309,996
Ensembl chr10:100,291,437...100,299,311

G

Cd300 molecule-like family member F

increases expression

benzo(b)fluoranthene results in increased expression of CD300LF mRNA

NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041

G

CD34 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD34 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD34 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832

G

CD36 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD36 mRNA

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD37 molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA

NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:95,719,190...95,724,648

G

CD38 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD38 mRNA

NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986

G

CD3 delta subunit of T-cell receptor complex

increases expression

benzo(b)fluoranthene results in increased expression of CD3D mRNA

NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809

G

Cd48 molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD48 mRNA

NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142

G

Cd69 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD69 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD69 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542

G

CD74 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD74 mRNA

NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003

G

CD79b molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD79B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD79B mRNA

PMID:26377693 PMID:27858113

NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625

G

CD93 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD93 mRNA

NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378

G

CD99 molecule (Xg blood group)

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD99 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CD99 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:54,418,239...54,422,882

G

cell division cycle 20

increases expression

benzo(b)fluoranthene results in increased expression of CDC20 mRNA

NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512

G

cell division cycle 25A

increases expression

benzo(b)fluoranthene results in increased expression of CDC25A mRNA

NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701

G

cell division cycle 40

decreases expression

benzo(b)fluoranthene results in decreased expression of CDC40 mRNA

NCBI chr20:44,273,080...44,325,605
Ensembl chr20:44,273,089...44,325,358

G

cell division cycle associated 3

increases expression

benzo(b)fluoranthene results in increased expression of CDCA3 mRNA

NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799

G

cell division cycle associated 5

increases expression

benzo(b)fluoranthene results in increased expression of CDCA5 mRNA

NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023

G

cell division cycle associated 8

increases expression

benzo(b)fluoranthene results in increased expression of CDCA8 mRNA

NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629

G

cadherin 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CDH1 mRNA

NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775

G

cadherin 16

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDH16 mRNA

NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007

G

cadherin 22

decreases expression

benzo(b)fluoranthene results in decreased expression of CDH22 mRNA

NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588

G

cadherin 5

increases expression

benzo(b)fluoranthene results in increased expression of CDH5 mRNA

NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368

G

cadherin-related family member 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDHR4 mRNA

NCBI chr 8:108,682,594...108,690,358
Ensembl chr 8:108,682,613...108,690,367

G

cyclin-dependent kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of CDK1 mRNA

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

cyclin dependent kinase 2

multiple interactions

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]

NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403

G

cyclin-dependent kinase inhibitor 1A

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CDKN1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CDKN1A mRNA

PMID:26377693 PMID:27858113

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1C

decreases expression

benzo(b)fluoranthene results in decreased expression of CDKN1C mRNA

NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048

G

cyclin-dependent kinase inhibitor 2A

decreases expression

benzo(b)fluoranthene results in decreased expression of CDKN2A mRNA

NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149

G

cyclin-dependent kinase inhibitor 2C

increases expression

benzo(b)fluoranthene results in increased expression of CDKN2C mRNA

NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278

G

cyclin-dependent kinase inhibitor 3

increases expression

benzo(b)fluoranthene results in increased expression of CDKN3 mRNA

NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945

G

chromatin licensing and DNA replication factor 1

increases expression

benzo(b)fluoranthene results in increased expression of CDT1 mRNA

NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659

G

CUGBP, Elav-like family member 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CELF5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

cadherin, EGF LAG seven-pass G-type receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CELSR1 mRNA

NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164

G

centromere protein A

increases expression

benzo(b)fluoranthene results in increased expression of CENPA mRNA

NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675

G

centromere protein E

increases expression

benzo(b)fluoranthene results in increased expression of CENPE mRNA

NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669

G

centromere protein K

increases expression

benzo(b)fluoranthene results in increased expression of CENPK mRNA

NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706

G

centromere protein P

increases expression

benzo(b)fluoranthene results in increased expression of CENPP mRNA

NCBI chr17:15,014,087...15,189,312
Ensembl chr17:15,014,058...15,189,304

G

centrosomal protein 162

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CEP162 mRNA

NCBI chr 8:88,149,726...88,208,249
Ensembl chr 8:88,149,726...88,206,830

G

centrosomal protein 164

increases expression

benzo(b)fluoranthene results in increased expression of CEP164 mRNA

NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336

G

centrosomal protein 250

increases expression

benzo(b)fluoranthene results in increased expression of CEP250 mRNA

NCBI chr 3:144,470,946...144,516,125
Ensembl chr 3:144,471,214...144,516,125

G

centrosomal protein 295

increases expression

benzo(b)fluoranthene results in increased expression of CEP295 mRNA

NCBI chr 8:12,156,568...12,194,542
Ensembl chr 8:12,156,554...12,194,552

G

centrosomal protein 95

increases expression

benzo(b)fluoranthene results in increased expression of CEP95 mRNA

NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092

G

carboxylesterase 2C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2C mRNA

NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790

G

carboxylesterase 2E

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2E mRNA
benzo(b)fluoranthene results in increased expression of CES2E mRNA

PMID:26377693 PMID:27858113

NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856

G

carboxylesterase 2H

increases expression

benzo(b)fluoranthene results in increased expression of CES2 mRNA

NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830

G

cilia and flagella associated protein 126

increases expression

benzo(b)fluoranthene results in increased expression of CFAP126 mRNA

NCBI chr13:83,526,657...83,542,552
Ensembl chr13:83,526,657...83,542,552

G

complement factor B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CFB mRNA

NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505

G

complement factor D

decreases expression

benzo(b)fluoranthene results in decreased expression of CFD mRNA

NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053

G

complement factor properdin

increases expression

benzo(b)fluoranthene results in increased expression of CFP mRNA

NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573

G

cyclic GMP-AMP synthase

increases expression

benzo(b)fluoranthene results in increased expression of CGAS mRNA

NCBI chr 8:79,292,282...79,306,998
Ensembl chr 8:79,294,511...79,305,496

G

cell growth regulator with EF hand domain 1

increases expression

benzo(b)fluoranthene results in increased expression of CGREF1 mRNA

NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852

G

chromatin assembly factor 1 subunit A

increases expression

benzo(b)fluoranthene results in increased expression of CHAF1A mRNA

NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654

G

chromatin assembly factor 1 subunit B

increases expression

benzo(b)fluoranthene results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CHD2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHD2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502

G

chromodomain helicase DNA binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of CHD6 mRNA

NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755

G

chitinase, acidic

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA

NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533

G

choline kinase alpha

decreases expression

benzo(b)fluoranthene results in decreased expression of CHKA mRNA

NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516

G

chondroitin polymerizing factor 2

increases expression

benzo(b)fluoranthene results in increased expression of CHPF2 mRNA

NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916

G

carbohydrate sulfotransferase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CHST1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHST1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883

G

carbohydrate sulfotransferase 3

increases expression

benzo(b)fluoranthene results in increased expression of CHST3 mRNA

NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807

G

carbohydrate sulfotransferase 7

decreases expression

benzo(b)fluoranthene results in decreased expression of CHST7 mRNA

NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840

G

circadian associated repressor of transcription

increases expression

benzo(b)fluoranthene results in increased expression of CIART mRNA

NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313

G

cell death-inducing DFFA-like effector c

decreases expression

benzo(b)fluoranthene results in decreased expression of CIDEC mRNA

NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173

G

cold inducible RNA binding protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CIRBP mRNA

NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818

G

cytokine inducible SH2-containing protein

increases expression

benzo(b)fluoranthene results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CITED2 mRNA

NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897

G

cytoskeleton associated protein 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CKAP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913

G

cytoskeleton associated protein 2-like

increases expression

benzo(b)fluoranthene results in increased expression of CKAP2L mRNA

NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366

G

CDC28 protein kinase regulatory subunit 1B

increases expression

benzo(b)fluoranthene results in increased expression of CKS1B mRNA

NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636

G

chloride channel accessory 2

increases expression

benzo(b)fluoranthene results in increased expression of CLCA2 mRNA

NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199

G

claudin 14

increases expression

benzo(b)fluoranthene results in increased expression of CLDN14 mRNA

NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171

G

C-type lectin domain containing 14A

decreases expression

benzo(b)fluoranthene results in decreased expression of CLEC14A mRNA

NCBI chr 6:75,881,470...75,884,612
Ensembl chr 6:75,881,473...75,884,612

G

C-type lectin domain family 1, member A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC1A mRNA

NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247

G

C-type lectin domain family 1, member B

decreases expression

benzo(b)fluoranthene results in decreased expression of CLEC1B mRNA

NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291

G

C-type lectin domain family 4, member A

increases expression

benzo(b)fluoranthene results in increased expression of CLEC4N mRNA

NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402

G

C-type lectin domain family 4, member A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC4A1 mRNA

NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008

G

C-type lectin domain family 4, member D

increases expression

benzo(b)fluoranthene results in increased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

C-type lectin domain family 4, member G

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CLEC4G mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CLEC4G mRNA

PMID:26377693 PMID:27858113

NCBI chr12:1,780,370...1,785,027
Ensembl chr12:1,780,371...1,784,985

G

chloride intracellular channel 1

increases expression

benzo(b)fluoranthene results in increased expression of CLIC1 mRNA

NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712

G

clock circadian regulator

decreases expression

benzo(b)fluoranthene results in decreased expression of CLOCK mRNA

NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400

G

calsyntenin 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLSTN2 mRNA

NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731

G

clathrin, light chain B

increases expression

benzo(b)fluoranthene results in increased expression of CLTB mRNA

NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169

G

cytidine/uridine monophosphate kinase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CMPK2 mRNA

NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183

G

cardiomyopathy associated 5

decreases expression

benzo(b)fluoranthene results in decreased expression of CMYA5 mRNA

NCBI chr 2:24,279,520...24,378,253
Ensembl chr 2:24,279,528...24,378,364

G

cornifelin

decreases expression

benzo(b)fluoranthene results in decreased expression of CNFN mRNA

NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747

G

cyclic nucleotide gated channel subunit beta 1

increases expression

benzo(b)fluoranthene results in increased expression of CNGB1 mRNA

NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173

G

cytochrome c oxidase assembly factor 8

decreases expression

benzo(b)fluoranthene results in decreased expression of COA8 mRNA

NCBI chr 6:130,772,218...130,797,081
Ensembl chr 6:130,771,199...130,797,081

G

cordon-bleu WH2 repeat protein

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of COBL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA

PMID:26377693 PMID:27858113

NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800

G

collagen type XIV alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL14A1 mRNA

NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214

G

collagen type XVIII alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL18A1 mRNA

NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593

G

collagen type I alpha 1 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A1 mRNA

NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624

G

collagen type I alpha 2 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA

NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867

G

collagen type XX alpha 1 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COL20A1 mRNA

NCBI chr 3:168,102,475...168,134,759
Ensembl chr 3:168,084,560...168,135,309

G

collagen type III alpha 1 chain

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COL3A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547

G

collagen type IV alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL4A1 mRNA

NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412

G

collagen type IV alpha 2 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL4A2 mRNA

NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839

G

collagen type IV alpha 4 chain

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of COL4A4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876

G

collagen type V alpha 3 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

COMM domain containing 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COMMD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COMMD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177

G

COMM domain containing 4

increases expression

benzo(b)fluoranthene results in increased expression of COMMD4 mRNA

NCBI chr 8:57,566,236...57,569,701
Ensembl chr 8:57,566,236...57,569,760

G

coenzyme Q10B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COQ10B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ10B mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663

G

coenzyme Q8A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ8A mRNA

NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431

G

coronin 2A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CORO2A mRNA

NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035

G

cytochrome c oxidase subunit 6B2

increases expression

benzo(b)fluoranthene results in increased expression of COX6B2 mRNA

NCBI chr 1:69,094,009...69,095,312

G

cytochrome c oxidase subunit 7A1

decreases expression

benzo(b)fluoranthene results in decreased expression of COX7A1 mRNA

NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151

G

ceruloplasmin

increases expression

benzo(b)fluoranthene results in increased expression of CP mRNA

NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075

G

complexin 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPLX2 mRNA

NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855

G

carboxypeptidase M

decreases expression

benzo(b)fluoranthene results in decreased expression of CPM mRNA

NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220

G

copine 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPNE4 mRNA

NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068

G

copine 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPNE5 mRNA

NCBI chr20:7,206,742...7,289,309
Ensembl chr20:7,206,742...7,288,883

G

calcineurin-like phosphoesterase domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of CPPED1 mRNA

NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054

G

carnitine palmitoyltransferase 1c

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA

NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342

G

complement C3d receptor 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:106,678,579...106,716,595
Ensembl chr13:106,685,413...106,716,235

G

CREB3 regulatory factor

increases expression

benzo(b)fluoranthene results in increased expression of CREBRF mRNA

NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999

G

CREB/ATF bZIP transcription factor

increases expression

benzo(b)fluoranthene results in increased expression of CREBZF mRNA

NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553

G

cellular repressor of E1A-stimulated genes 1

increases expression

benzo(b)fluoranthene results in increased expression of CREG1 mRNA

NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308

G

cAMP responsive element modulator

increases expression

benzo(b)fluoranthene results in increased expression of CREM mRNA

NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989

G

cysteine-rich secretory protein 3

increases expression

benzo(b)fluoranthene results in increased expression of CRISP3 mRNA

NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658

G

CRK proto-oncogene, adaptor protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CRK mRNA

NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406

G

cytokine receptor-like factor 2

increases expression

benzo(b)fluoranthene results in increased expression of CRLF2 mRNA

NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642

G

cysteine sulfinic acid decarboxylase

decreases expression

benzo(b)fluoranthene results in decreased expression of CSAD mRNA

NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615

G

colony stimulating factor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

colony stimulating factor 2 receptor subunit alpha

increases expression

benzo(b)fluoranthene results in increased expression of CSF2RA mRNA

NCBI chr14:98,089...103,261
Ensembl chr14:89,172...103,128

G

cysteine and serine rich nuclear protein 1

increases expression

benzo(b)fluoranthene results in increased expression of CSRNP1 mRNA

NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183

G

cystatin 8

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CST8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CST8 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:136,244,586...136,255,412
Ensembl chr 3:136,244,636...136,251,273

G

cystathionine gamma-lyase

decreases expression

benzo(b)fluoranthene results in decreased expression of CTH mRNA

NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234

G

CTP synthase 2

increases expression

benzo(b)fluoranthene results in increased expression of CTPS2 mRNA

NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733

G

cathepsin D

increases expression

benzo(b)fluoranthene results in increased expression of CTSD mRNA

NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488

G

cathepsin H

increases expression

benzo(b)fluoranthene results in increased expression of CTSH mRNA

NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824

G

cathepsin S

increases expression

benzo(b)fluoranthene results in increased expression of CTSS mRNA

NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483

G

C-X3-C motif chemokine ligand 1

affects expression

benzo(b)fluoranthene affects the expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X3-C motif chemokine receptor 1

affects expression

benzo(b)fluoranthene affects the expression of CX3CR1 mRNA

NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014

G

C-X-C motif chemokine ligand 10

increases expression

benzo(b)fluoranthene results in increased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 13

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA

NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933

G

C-X-C motif chemokine ligand 16

increases expression

benzo(b)fluoranthene results in increased expression of CXCL16 mRNA

NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592

G

C-X-C motif chemokine ligand 3

decreases expression

benzo(b)fluoranthene results in decreased expression of CXCL1 mRNA

NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511

G

C-X-C motif chemokine ligand 6

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA
benzo(b)fluoranthene results in decreased expression of CXCL5 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093

G

C-X-C motif chemokine receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of CXCR2 mRNA

NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425

G

C-X-C motif chemokine receptor 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CXCR5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR5 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893

G

C-X-C motif chemokine receptor 6

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CXCR6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCR6 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526

G

cytochrome b5 type A

increases expression

benzo(b)fluoranthene results in increased expression of CYB5A mRNA

NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535

G

CYLD lysine 63 deubiquitinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYLD mRNA

NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658

G

cytochrome P450, family 17, subfamily a, polypeptide 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA

NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases activity
increases expression
decreases expression
affects expression

[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 protein; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A1 mRNA; [Docosahexaenoic Acids co-treated with benzo(b)fluoranthene] results in decreased expression of CYP1A1 mRNA; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; benzo(b)fluoranthene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; Cadmium Chloride inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA
[chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; benzo(b)fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; benzo(b)fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA; benzo(b)fluoranthene results in increased expression of CYP1A1 protein
benzo(b)fluoranthene results in decreased expression of CYP1A1 mRNA
benzo(b)fluoranthene affects the expression of CYP1A1 mRNA

PMID:7750161 PMID:10190573 PMID:11162773 PMID:11408366 PMID:12117779 More...

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression
multiple interactions
decreases activity

benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA
[fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA
benzo(b)fluoranthene results in decreased activity of CYP1A2 protein
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA

PMID:7750161 PMID:11162773 PMID:12117779 PMID:16269432 PMID:17253728 More...

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

multiple interactions
increases expression
affects expression

[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 protein; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA
benzo(b)fluoranthene results in increased expression of CYP1B1 mRNA
[benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; [chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; benzo(b)fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
benzo(b)fluoranthene affects the expression of CYP1B1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA

PMID:12117779 PMID:15566942 PMID:17961608 PMID:26377693 PMID:27099206 More...

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYP26B1 mRNA

NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628

G

cytochrome P450, family 2, subfamily b, polypeptide 2

increases expression

benzo(b)fluoranthene results in increased expression of CYP2B13 mRNA

NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases expression

benzo(b)fluoranthene results in increased expression of CYP2B10 mRNA

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily d, polypeptide 4

increases expression

benzo(b)fluoranthene results in increased expression of CYP2D6 mRNA

NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP2E1 mRNA

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 2, subfamily g, polypeptide 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP2G1 mRNA

NCBI chr 1:82,145,635...82,156,862
Ensembl chr 1:82,145,073...82,156,828

G

cytochrome P450, family 4, subfamily b, polypeptide 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYP4B1 mRNA

NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348

G

cytochrome P450 family 7 subfamily B member 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP7B1 mRNA

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

cystin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYS1 mRNA

NCBI chr 6:41,300,836...41,318,071
Ensembl chr 6:41,300,836...41,318,071

G

cytohesin 2

increases expression

benzo(b)fluoranthene results in increased expression of CYTH2 mRNA

NCBI chr 1:96,283,182...96,291,094
Ensembl chr 1:96,284,252...96,291,092

G

cytokine like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYTL1 mRNA

NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886

G

DAB adaptor protein 2

increases expression

benzo(b)fluoranthene results in increased expression of DAB2 mRNA

NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476

G

dachshund family transcription factor 1

increases expression

benzo(b)fluoranthene results in increased expression of DACH1 mRNA

NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922

G

differentiation antagonizing non-protein coding RNA

affects expression

benzo(b)fluoranthene affects the expression of DANCR mRNA

NCBI chr14:34,126,956...34,127,936

G

death associated protein-like 1

increases expression

benzo(b)fluoranthene results in increased expression of DAPL1 mRNA

NCBI chr 3:43,960,993...43,980,940
Ensembl chr 3:43,960,810...43,980,940

G

aspartyl-tRNA synthetase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DARS1 mRNA

NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116

G

diazepam binding inhibitor

decreases expression

benzo(b)fluoranthene results in decreased expression of DBI mRNA

NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693

G

D-box binding PAR bZIP transcription factor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DBP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DBP mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

DDB1 and CUL4 associated factor 12-like 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DCAF12L2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:123,293,761...123,296,550
Ensembl chr X:123,294,744...123,296,156

G

DDB1 and CUL4 associated factor 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA

NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982

G

DCC netrin 1 receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCC mRNA

NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740

G

decorin

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DCN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCN mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270

G

dimethylarginine dimethylaminohydrolase 1

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of DDAH1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339

G

dopa decarboxylase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDC mRNA

NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208

G

DNA damage-induced apoptosis suppressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DDIAS mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIAS mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462

G

DNA-damage-inducible transcript 4-like

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DDIT4L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIT4L mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375

G

DEAD-box helicase 25

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX25 mRNA

NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764

G

DEAD-box helicase 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX5 mRNA

NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283

G

DEF6 guanine nucleotide exchange factor

increases expression

benzo(b)fluoranthene results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961

G

DEP domain containing 1B

increases expression

benzo(b)fluoranthene results in increased expression of DEPDC1B mRNA

NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779

G

diacylglycerol O-acyltransferase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA

NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428

G

24-dehydrocholesterol reductase

increases expression

benzo(b)fluoranthene results in increased expression of DHCR24 mRNA

NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137

G

diaphanous-related formin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIAP1 mRNA

NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172

G

diaphanous-related formin 3

increases expression

benzo(b)fluoranthene results in increased expression of DIAPH3 mRNA

NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975

G

death inducer-obliterator 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIDO1 mRNA

NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218

G

iodothyronine deiodinase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of DIO1 mRNA

NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970

G

divergent protein kinase domain 1B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DIPK1B mRNA

NCBI chr 3:9,455,914...9,464,169
Ensembl chr 3:9,456,409...9,464,161

G

dispatched RND transporter family member 2

increases expression

benzo(b)fluoranthene results in increased expression of DISP2 mRNA

NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800

G

dematin actin binding protein

increases expression

benzo(b)fluoranthene results in increased expression of DMTN mRNA

NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601

G

dynein axonemal assembly factor 10

increases expression

benzo(b)fluoranthene results in increased expression of DNAAF10 mRNA

NCBI chr14:91,618,649...91,639,828
Ensembl chr14:91,636,157...91,639,831

G

dynein, axonemal, heavy chain 8

decreases expression

benzo(b)fluoranthene results in decreased expression of DNAH8 mRNA

NCBI chr20:8,692,939...8,946,780
Ensembl chr20:8,692,963...8,946,772

G

DnaJ heat shock protein family (Hsp40) member A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJA1 mRNA

NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967

G

DnaJ heat shock protein family (Hsp40) member B11

increases expression

benzo(b)fluoranthene results in increased expression of DNAJB11 mRNA

NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407

G

DnaJ heat shock protein family (Hsp40) member B4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA

NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089

G

DnaJ heat shock protein family (Hsp40) member C8

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA

NCBI chr 5:144,745,055...144,763,106
Ensembl chr 5:144,745,036...144,763,108

G

deoxyribonuclease 1 like 2

increases expression

benzo(b)fluoranthene results in increased expression of DNASE1L2 mRNA

NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763

G

DNA methyltransferase 3 alpha

increases expression

benzo(b)fluoranthene results in increased expression of DNMT3A mRNA

NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687

G

docking protein 3

increases expression

benzo(b)fluoranthene results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188

G

dolichyl-phosphate N-acetylglucosaminephosphotransferase 1

increases expression

benzo(b)fluoranthene results in increased expression of DPAGT1 mRNA

NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087

G

dipeptidase 2

increases expression

benzo(b)fluoranthene results in increased expression of DPEP2 mRNA

NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954

G

dopamine receptor D1

multiple interactions

[Particulate Matter results in increased abundance of benzo(b)fluoranthene] which results in decreased expression of DRD1 mRNA

NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002

G

denticleless E3 ubiquitin protein ligase homolog

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DTL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DTL mRNA

PMID:26377693 PMID:27858113

NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890

G

deltex E3 ubiquitin ligase 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DTX4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DTX4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818

G

dishevelled segment polarity protein 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DVL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DVL3 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462

G

dynein cytoplasmic 1 intermediate chain 1

increases expression

benzo(b)fluoranthene results in increased expression of DYNC1I1 mRNA

NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149

G

dysferlin

increases expression

benzo(b)fluoranthene results in increased expression of DYSF mRNA

NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709

G

DAZ interacting zinc finger protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DZIP1 mRNA

NCBI chr15:95,956,329...96,009,994
Ensembl chr15:95,956,398...96,010,066

G

E2F transcription factor 3

increases expression

benzo(b)fluoranthene results in increased expression of E2F3 mRNA

NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253

G

E2F transcription factor 7

increases expression

benzo(b)fluoranthene results in increased expression of E2F7 mRNA

NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734

G

E2F transcription factor 8

increases expression

benzo(b)fluoranthene results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

endothelin converting enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ECE1 mRNA

NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371

G

enoyl CoA hydratase domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of ECHDC2 mRNA

NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859

G

extracellular matrix protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ECM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ECM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671

G

epithelial cell transforming 2

increases expression

benzo(b)fluoranthene results in increased expression of ECT2 mRNA

NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911

G

EGF like repeats and discoidin domains 3

increases expression

benzo(b)fluoranthene results in increased expression of EDIL3 mRNA

NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008

G

endothelin receptor type B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EDNRB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA

PMID:26377693 PMID:27858113

NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115

G

EGF containing fibulin extracellular matrix protein 2

increases expression

benzo(b)fluoranthene results in increased expression of EFEMP2 mRNA

NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414

G

ephrin A1

decreases expression

benzo(b)fluoranthene results in decreased expression of EFNA1 mRNA

NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866

G

ephrin B1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EFNB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:64,257,351...64,270,158
Ensembl chr X:64,257,351...64,270,157

G

EGF-like-domain, multiple 7

increases expression

benzo(b)fluoranthene results in increased expression of EGFL7 mRNA

NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879

G

epidermal growth factor receptor

multiple interactions
decreases expression

benzo(b)fluoranthene affects the localization of and results in increased expression of EGFR protein
benzo(b)fluoranthene results in decreased expression of EGFR mRNA

PMID:21776270 PMID:26377693

NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382

G

early growth response 1

increases expression

benzo(b)fluoranthene results in increased expression of EGR1 mRNA
benzo(b)fluoranthene results in increased expression of EGR1 mRNA; benzo(b)fluoranthene results in increased expression of EGR1 protein

PMID:26377693 PMID:29787794

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

EH domain binding protein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EHBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EHBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332

G

EH-domain containing 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD1 mRNA

NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212

G

EH-domain containing 3

increases expression

benzo(b)fluoranthene results in increased expression of EHD3 mRNA

NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236

G

EH-domain containing 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EHD4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002

G

ets homologous factor

decreases expression

benzo(b)fluoranthene results in decreased expression of EHF mRNA

NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997

G

EP300 interacting inhibitor of differentiation 1

increases expression

benzo(b)fluoranthene results in increased expression of EID1 mRNA

NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752

G

ELOVL fatty acid elongase 1

increases expression

benzo(b)fluoranthene results in increased expression of ELOVL1 mRNA

NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958

G

endomucin

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EMCN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929

G

EMI domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of EMID1 mRNA

NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620

G

EMAP like 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EML1 mRNA

NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246

G

epithelial membrane protein 1

increases expression

benzo(b)fluoranthene results in increased expression of EMP1 mRNA

NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904

G

endonuclease, poly(U)-specific

increases expression

benzo(b)fluoranthene results in increased expression of ENDOU mRNA

NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:128,844,862...128,866,596

G

enolase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of ENO3 mRNA

NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921

G

ectonucleoside triphosphate diphosphohydrolase 2

increases expression

benzo(b)fluoranthene results in increased expression of ENTPD2 mRNA

NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866

G

endosomal transmembrane epsin interactor 3

increases expression

benzo(b)fluoranthene results in increased expression of ENTREP3 mRNA

NCBI chr 2:174,588,984...174,595,281
Ensembl chr 2:174,589,337...174,595,281

G

erythrocyte membrane protein band 4.1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EPB41 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EPB41 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:144,110,010...144,264,037
Ensembl chr 5:144,111,906...144,237,821

G

Eph receptor A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA

NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846

G

Eph receptor A2

increases expression

benzo(b)fluoranthene results in increased expression of EPHA2 mRNA

NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117

G

epoxide hydrolase 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EPHX1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHX1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

epsin 2

decreases expression

benzo(b)fluoranthene results in decreased expression of EPN2 mRNA

NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642

G

erythropoietin receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPOR mRNA

NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257

G

Ets2 repressor factor

increases expression

benzo(b)fluoranthene results in increased expression of ERF mRNA

NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388

G

ermin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA

NCBI chr 3:42,628,160...42,633,816
Ensembl chr 3:42,626,309...42,633,744

G

endothelial cell adhesion molecule

increases expression

benzo(b)fluoranthene results in increased expression of ESAM mRNA

NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215

G

endothelial cell-specific molecule 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ESM1 mRNA

NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804

G

estrogen receptor 1

increases expression
increases activity

benzo(b)fluoranthene results in increased expression of ESR1 protein
benzo(b)fluoranthene results in increased activity of ESR1 protein

PMID:21392559 PMID:28728110

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

ETHE1, persulfide dioxygenase

decreases expression

benzo(b)fluoranthene results in decreased expression of ETHE1 mRNA

NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052

G

eva-1 homolog A, regulator of programmed cell death

increases expression

benzo(b)fluoranthene results in increased expression of EVA1A mRNA

NCBI chr 4:114,593,773...114,643,011
Ensembl chr 4:114,593,341...114,643,011

G

exonuclease 1

increases expression

benzo(b)fluoranthene results in increased expression of EXO1 mRNA

NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654

G

exocyst complex component 3-like 2

increases expression

benzo(b)fluoranthene results in increased expression of EXOC3L2 mRNA

NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465

G

exocyst complex component 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EXOC4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EXOC4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:61,807,706...62,584,316
Ensembl chr 4:61,807,761...62,585,723

G

coagulation factor XIII A1 chain

increases expression

benzo(b)fluoranthene results in increased expression of F13A1 mRNA

NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700

G

coagulation factor III, tissue factor

increases expression

benzo(b)fluoranthene results in increased expression of F3 protein

NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668

G

fatty acid binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

fatty acid binding protein 12

increases expression

benzo(b)fluoranthene results in increased expression of FABP12 mRNA

NCBI chr 2:91,539,568...91,554,999
Ensembl chr 2:91,500,539...91,554,996

G

fatty acid binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FABP3 mRNA

NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718

G

fatty acid binding protein 4

decreases expression

benzo(b)fluoranthene results in decreased expression of FABP4 mRNA

NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578

G

fatty acid binding protein 5

increases expression

benzo(b)fluoranthene results in increased expression of FABP5 mRNA

NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773

G

family with sequence similarity 107, member A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA

NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396

G

family with sequence similarity 110, member D

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM110D mRNA
benzo(b)fluoranthene results in decreased expression of FAM110D mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:146,471,048...146,474,019
Ensembl chr 5:146,471,049...146,474,056

G

FAM111 trypsin like peptidase A

increases expression

benzo(b)fluoranthene results in increased expression of FAM111A mRNA

NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547

G

family with sequence similarity 133, member B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FAM133B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM133B mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:30,589,646...30,616,291
Ensembl chr 4:30,589,635...30,616,040

G

family with sequence similarity 13, member A

increases expression

benzo(b)fluoranthene results in increased expression of FAM13A mRNA

NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860

G

family with sequence similarity 13, member C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM13C mRNA

NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592

G

family with sequence similarity 193, member B

increases expression

benzo(b)fluoranthene results in increased expression of FAM193B mRNA

NCBI chr17:9,066,818...9,099,511
Ensembl chr17:9,066,707...9,099,508

G

FAM20B, glycosaminoglycan xylosylkinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM20B mRNA

NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915

G

family with sequence similarity 43, member A

increases expression

benzo(b)fluoranthene results in increased expression of FAM43A mRNA

NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401

G

FA complementation group B

decreases expression

benzo(b)fluoranthene results in decreased expression of FANCB mRNA

NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA

NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299

G

fatty acid synthase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FASN mRNA

NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261

G

Fas-activated serine/threonine kinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA

NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430

G

F-box and leucine-rich repeat protein 4

increases expression

benzo(b)fluoranthene results in increased expression of FBXL4 mRNA

NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443

G

F-box protein 5

increases expression

benzo(b)fluoranthene results in increased expression of FBXO5 mRNA

NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437

G

Fc epsilon receptor II

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FCER2A mRNA

NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476

G

FCH and double SH3 domains 2

increases expression

benzo(b)fluoranthene results in increased expression of FCHSD2 mRNA

NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539

G

Fc mu receptor

increases expression

benzo(b)fluoranthene results in increased expression of FCMR mRNA

NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653

G

Fc receptor-like A

increases expression

benzo(b)fluoranthene results in increased expression of FCRLA mRNA

NCBI chr13:83,160,453...83,170,170
Ensembl chr13:83,160,398...83,170,762

G

FES proto-oncogene, tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of FES mRNA

NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934

G

fasciculation and elongation protein zeta 2

increases expression

benzo(b)fluoranthene results in increased expression of FEZ2 mRNA

NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626

G

fibrinogen alpha chain

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FGA mRNA

NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528

G

FYVE, RhoGEF and PH domain containing 5

increases expression

benzo(b)fluoranthene results in increased expression of FGD5 mRNA

NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563

G

fibroblast growth factor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of FGF1 mRNA

NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357

G

fibroblast growth factor 9

increases expression

benzo(b)fluoranthene results in increased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

FGFR1 oncogene partner 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FGFR1OP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:179,491,602...179,512,630
Ensembl chr 4:179,491,599...179,512,630

G

fibroblast growth factor receptor 3

increases expression

benzo(b)fluoranthene results in increased expression of FGFR3 mRNA

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

fibrinogen gamma chain

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FGG mRNA

NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322

G

fibrinogen-like 1

increases expression

benzo(b)fluoranthene results in increased expression of FGL1 mRNA

NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093

G

four and a half LIM domains 2

decreases expression

benzo(b)fluoranthene results in decreased expression of FHL2 mRNA

NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192

G

formin homology 2 domain containing 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FHOD3 mRNA

NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796

G

fin bud initiation factor homolog

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FIBIN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FIBIN mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

FIG4 phosphoinositide 5-phosphatase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIG4 mRNA

NCBI chr20:44,600,603...44,724,047
Ensembl chr20:44,600,603...44,723,844

G

fidgetin, microtubule severing factor

decreases expression

benzo(b)fluoranthene results in decreased expression of FIGN mRNA

NCBI chr 3:48,637,510...48,760,772
Ensembl chr 3:48,642,496...48,760,787

G

fidgetin-like 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of FIGNL1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIGNL1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455

G

filamin A interacting protein 1-like

increases expression

benzo(b)fluoranthene results in increased expression of FILIP1L mRNA

NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415

G

four-jointed box kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of FJX1 mRNA

NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321

G

FKBP prolyl isomerase 14

increases expression

benzo(b)fluoranthene results in increased expression of FKBP14 mRNA

NCBI chr 4:83,705,531...83,721,515
Ensembl chr 4:83,705,652...83,721,528

G

FKBP prolyl isomerase 1A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FKBP1A mRNA

NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743

G

folliculin

increases expression

benzo(b)fluoranthene results in increased expression of FLCN mRNA

NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769

G

FLII, actin remodeling protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FLII mRNA

NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970

G

filamin B

increases expression

benzo(b)fluoranthene results in increased expression of FLNB mRNA

NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006

G

fibronectin leucine rich transmembrane protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FLRT3 mRNA

NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841

G

FLVCR choline and putative heme transporter 2

decreases expression

benzo(b)fluoranthene results in decreased expression of FLVCR2 mRNA

NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353

G

formin 2

increases expression

benzo(b)fluoranthene results in increased expression of FMN2 mRNA

NCBI chr13:86,454,256...86,771,437
Ensembl chr13:86,453,926...86,771,411

G

flavin containing dimethylaniline monoxygenase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FMO1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647

G

flavin containing dimethylaniline monoxygenase 3

increases expression

benzo(b)fluoranthene results in increased expression of FMO3 mRNA

NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028

G

flavin containing dimethylaniline monoxygenase 5

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FMO5 mRNA

NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693

G

fragile X messenger ribonucleoprotein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FMR1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMR1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050

G

fibronectin type III domain containing 1

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of FNDC1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FNDC1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259

G

forkhead box A1

decreases expression

benzo(b)fluoranthene results in decreased expression of FOXA1 mRNA

NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188

G

forkhead box A3

increases expression

benzo(b)fluoranthene results in increased expression of FOXA3 mRNA

NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155

G

forkhead box F1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of FOXF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FOXF1 mRNA

PMID:26377693 PMID:27858113

NCBI chr19:49,153,949...49,157,741
Ensembl chr19:49,153,699...49,157,738

G

forkhead box Q1

increases expression

benzo(b)fluoranthene results in increased expression of FOXQ1 mRNA

NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377

G

forkhead box S1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FOXS1 mRNA

NCBI chr 3:141,397,012...141,398,296
Ensembl chr 3:141,397,016...141,398,281

G

FSHD region gene 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FRG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRG1 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:50,925,783...50,946,661
Ensembl chr16:50,925,803...50,946,661

G

FERM domain containing 4B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRMD4B mRNA

NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197

G

fascin actin-bundling protein 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA

NCBI chr 4:57,042,797...57,052,224
Ensembl chr 4:57,042,797...57,052,404

G

FXYD domain-containing ion transport regulator 5

increases expression

benzo(b)fluoranthene results in increased expression of FXYD5 mRNA

NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519

G

frizzled class receptor 4

decreases expression

benzo(b)fluoranthene results in decreased expression of FZD4 mRNA

NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724

G

glucose-6-phosphate dehydrogenase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of G6PD mRNA

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

alpha glucosidase

increases expression

benzo(b)fluoranthene results in increased expression of GAA mRNA

NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836

G

gamma-aminobutyric acid type A receptor subunit pi

decreases expression

benzo(b)fluoranthene results in decreased expression of GABRP mRNA

NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516

G

growth arrest and DNA-damage-inducible, alpha

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

growth arrest and DNA-damage-inducible, gamma

increases expression

benzo(b)fluoranthene results in increased expression of GADD45G mRNA

NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610

G

galactose-3-O-sulfotransferase 2

increases expression

benzo(b)fluoranthene results in increased expression of GAL3ST2 mRNA

NCBI chr 9:94,382,456...94,387,990

G

polypeptide N-acetylgalactosaminyltransferase 15

decreases expression

benzo(b)fluoranthene results in decreased expression of GALNT15 mRNA

NCBI chr16:7,227,232...7,267,002
Ensembl chr16:7,227,271...7,267,014

G

growth associated protein 43

increases expression

benzo(b)fluoranthene results in increased expression of GAP43 mRNA

NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045

G

growth arrest specific 5

increases expression

benzo(b)fluoranthene results in increased expression of GAS5 mRNA

NCBI chr13:73,303,611...73,306,932

G

growth arrest specific 6

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GAS6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GAS6 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904

G

golgi associated kinase 1B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GASK1B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GASK1B mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477

G

GATA binding protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GATA2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GATA2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761

G

GATA binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of GATA3 mRNA

NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391

G

GATA binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of GATA6 mRNA

NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532

G

GC, vitamin D binding protein

increases expression

benzo(b)fluoranthene results in increased expression of GC mRNA

NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567

G

GRIP and coiled-coil domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of GCC2 mRNA

NCBI chr20:26,247,394...26,293,613
Ensembl chr20:26,247,404...26,293,613

G

glucagon receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GCGR mRNA

NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640

G

GTP cyclohydrolase 1

increases expression

benzo(b)fluoranthene results in increased expression of GCH1 mRNA

NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698

G

glucokinase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GCK mRNA

NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995

G

glial cells missing transcription factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GCM1 mRNA

NCBI chr 8:78,925,687...78,938,924
Ensembl chr 8:78,925,687...78,938,924

G

guanine deaminase

increases expression

benzo(b)fluoranthene results in increased expression of GDA mRNA

NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416

G

growth differentiation factor 15

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GDF15 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

glycerophosphodiester phosphodiesterase domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of GDPD2 mRNA

NCBI chr X:65,826,273...65,835,361
Ensembl chr X:65,826,574...65,835,361

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

benzo(b)fluoranthene results in increased expression of GDPD5 mRNA

NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446

G

GDNF family receptor alpha 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GFRA4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GFRA4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:118,254,937...118,262,252
Ensembl chr 3:118,255,402...118,258,329

G

GTPase, IMAP family member 6

increases expression

benzo(b)fluoranthene results in increased expression of GIMAP6 mRNA

NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116

G

gap junction protein, alpha 4

increases expression

benzo(b)fluoranthene results in increased expression of GJA4 mRNA

NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925

G

gap junction protein, beta 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GJB1 mRNA

NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925

G

galactosidase, beta 1-like 2

decreases expression

benzo(b)fluoranthene results in decreased expression of GLB1L2 mRNA

NCBI chr 8:25,115,462...25,166,843
Ensembl chr 8:25,115,462...25,166,783

G

glycine decarboxylase

decreases expression

benzo(b)fluoranthene results in decreased expression of GLDC mRNA

NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097

G

gliomedin

increases expression

benzo(b)fluoranthene results in increased expression of GLDN mRNA

NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196

G

GLIS family zinc finger 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GLIS2 mRNA

NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578

G

glyoxalase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GLO1 mRNA

NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649

G

geminin, DNA replication inhibitor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GMNN mRNA

NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054

G

G protein subunit alpha 14

decreases expression

benzo(b)fluoranthene results in decreased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha i1

increases expression

benzo(b)fluoranthene results in increased expression of GNAI1 mRNA

NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417

G

G protein subunit alpha transducin 1

increases expression

benzo(b)fluoranthene results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671

G

golgin A7 family, member B

decreases expression

benzo(b)fluoranthene results in decreased expression of GOLGA7B mRNA

NCBI chr 1:241,056,427...241,080,890
Ensembl chr 1:241,059,171...241,079,081

G

golgi membrane protein 1

increases expression

benzo(b)fluoranthene results in increased expression of GOLM1 mRNA

NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057

G

glycoprotein IX (platelet)

decreases expression

benzo(b)fluoranthene results in decreased expression of GP9 mRNA

NCBI chr 4:120,235,500...120,237,110
Ensembl chr 4:120,235,421...120,237,110

G

glycerol-3-phosphate dehydrogenase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GPD1 mRNA

NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GPIHBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPIHBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702

G

G protein-coupled receptor 146

increases expression

benzo(b)fluoranthene results in increased expression of GPR146 mRNA

NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206

G

G protein-coupled receptor 162

decreases expression

benzo(b)fluoranthene results in decreased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor 182

decreases expression

benzo(b)fluoranthene results in decreased expression of GPR182 mRNA

NCBI chr 7:63,585,997...63,589,088
Ensembl chr 7:63,578,750...63,589,210

G

G protein-coupled receptor 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GPR4 mRNA

NCBI chr 1:78,865,376...78,877,126
Ensembl chr 1:78,865,409...78,876,599

G

GPRIN family member 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GPRIN3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPRIN3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:88,572,062...88,657,369
Ensembl chr 4:88,563,607...88,657,429

G

growth factor receptor bound protein 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRB10 mRNA

NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806

G

growth regulating estrogen receptor binding 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GREB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GREB1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 2, DAN family BMP antagonist

increases expression

benzo(b)fluoranthene results in increased expression of GREM2 mRNA

NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615

G

glutamate ionotropic receptor AMPA type subunit 3

increases expression

benzo(b)fluoranthene results in increased expression of GRIA3 mRNA

NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096

G

galectin-related inter-fiber protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRIFIN mRNA

NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877

G

glutamate ionotropic receptor NMDA type subunit 2C

increases expression

benzo(b)fluoranthene results in increased expression of GRIN2C mRNA

NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427

G

G protein-coupled receptor kinase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of GRK3 mRNA

NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262

G

gastrin releasing peptide

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GRP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA

PMID:26377693 PMID:27858113

NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061

G

gasdermin D

increases expression

benzo(b)fluoranthene results in increased expression of GSDMD mRNA

NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055

G

gasdermin E

increases expression

benzo(b)fluoranthene results in increased expression of GSDME mRNA

NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806

G

glutathione S-transferase mu 1

multiple interactions

[Docosahexaenoic Acids co-treated with benzo(b)fluoranthene] results in decreased expression of GSTM1 protein

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

general transcription factor IIB

increases expression

benzo(b)fluoranthene results in increased expression of GTF2B mRNA

NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651

G

general transcription factor IIE subunit 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GTF2E1 mRNA

NCBI chr11:63,182,073...63,215,349
Ensembl chr11:63,182,349...63,213,942

G

granzyme A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GZMA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GZMA mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493

G

H1.2 linker histone, cluster member

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of H1F2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635

G

H1.4 linker histone, cluster member

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H1F4 mRNA

NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403

G

H1.5 linker histone, cluster member

increases expression

benzo(b)fluoranthene results in increased expression of H1F5 mRNA

NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160

G

H2A clustered histone 25

increases expression

benzo(b)fluoranthene results in increased expression of H2AC25 mRNA

NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874

G

H2A.J histone

increases expression

benzo(b)fluoranthene results in increased expression of H2AJ mRNA

NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006

G

H2A.Z variant histone 1

increases expression

benzo(b)fluoranthene results in increased expression of H2AZ1 mRNA

NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485

G

H2B clustered histone 1

increases expression

benzo(b)fluoranthene results in increased expression of H2BC1 mRNA

NCBI chr17:41,172,041...41,172,510
Ensembl chr17:41,171,903...41,176,782
Ensembl chr17:41,171,903...41,176,782

G

H2B clustered histone 6

increases expression

benzo(b)fluoranthene results in increased expression of H2BC6 mRNA

NCBI chr17:41,520,775...41,521,238

G

hepcidin antimicrobial peptide

increases expression
decreases expression

benzo(b)fluoranthene results in increased expression of HAMP mRNA
benzo(b)fluoranthene results in decreased expression of HAMP mRNA

PMID:16269432 PMID:26377693

NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891

G

huntingtin-associated protein 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HAP1 mRNA

NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126

G

histone H3 associated protein kinase

increases expression

benzo(b)fluoranthene results in increased expression of HASPIN mRNA

NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512

G

histone deacetylase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HDAC1 mRNA

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

HEAT repeat containing 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HEATR1 mRNA

NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948

G

HEXIM P-TEFb complex subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of HEXIM2 mRNA

NCBI chr10:88,077,870...88,084,776
Ensembl chr10:88,079,014...88,084,775

G

hes-related family bHLH transcription factor with YRPW motif 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HEY1 mRNA

NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312

G

HIC ZBTB transcriptional repressor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HIC1 mRNA

NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475

G

hypoxia inducible factor 1 subunit alpha

increases activity
multiple interactions

benzo(b)fluoranthene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HIF1A mRNA

PMID:17690111 PMID:19502547

NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261

G

HIG1 hypoxia inducible domain family, member 2A

increases expression

benzo(b)fluoranthene results in increased expression of HIGD2A mRNA

NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796

G

hypoxia inducible lipid droplet-associated

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HILPDA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557

G

histone cluster 1 H2A family member H

increases expression

benzo(b)fluoranthene results in increased expression of H2AC22 mRNA

NCBI chr17:41,384,521...41,385,018

G

histone cluster 1, H2bc

increases expression

benzo(b)fluoranthene results in increased expression of H2BC4 mRNA

NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642

G

hexokinase domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of HKDC1 mRNA

NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867

G

HLF transcription factor, PAR bZIP family member

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of HLF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HLF mRNA

PMID:26377693 PMID:27858113

NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935

G

H2.0-like homeobox

increases expression

benzo(b)fluoranthene results in increased expression of HLX mRNA

NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750

G

histocompatibility minor 13

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H13 mRNA

NCBI chr 3:141,145,792...141,183,557
Ensembl chr 3:141,145,782...141,184,703

G

homeobox containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HMBOX1 mRNA

NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323

G

hemicentin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMCN1 mRNA

NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524

G

high mobility group 20 B

increases expression

benzo(b)fluoranthene results in increased expression of HMG20B mRNA

NCBI chr 7:8,368,934...8,373,650
Ensembl chr 7:8,368,990...8,373,640

G

high mobility group AT-hook 1

increases expression

benzo(b)fluoranthene results in increased expression of HMGA1 mRNA

NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752

G

high mobility group box 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGB1 mRNA

NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565

G

high mobility group box 2

increases expression

benzo(b)fluoranthene results in increased expression of HMGB2 mRNA

NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140

G

3-hydroxy-3-methylglutaryl-CoA reductase

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HMGCR mRNA
benzo(b)fluoranthene results in decreased expression of HMGCR mRNA

PMID:16269432 PMID:17690111

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HMGCS1 mRNA

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100

G

high mobility group nucleosomal binding domain 2

increases expression

benzo(b)fluoranthene results in increased expression of HMGN2 mRNA

NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521
Ensembl chr16:146,192,126...146,195,521

G

high mobility group nucleosome binding domain 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGN5 mRNA

NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441

G

heme oxygenase 1

increases expression

benzo(b)fluoranthene results in increased expression of HMOX1 mRNA

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

heterogeneous nuclear ribonucleoprotein D-like

increases expression

benzo(b)fluoranthene results in increased expression of HNRNPDL mRNA

NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506

G

heterogeneous nuclear ribonucleoprotein F

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA

NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038

G

homer scaffold protein 3

increases expression

benzo(b)fluoranthene results in increased expression of HOMER3 mRNA

NCBI chr16:19,132,177...19,142,739
Ensembl chr16:19,132,162...19,142,680

G

homeo box B3

decreases expression

benzo(b)fluoranthene results in decreased expression of HOXB3 mRNA

NCBI chr10:81,258,739...81,314,134
Ensembl chr10:81,299,357...81,313,107

G

homeo box B5

decreases expression

benzo(b)fluoranthene results in decreased expression of HOXB5 mRNA

NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580

G

hippocalcin-like 4

increases expression

benzo(b)fluoranthene results in increased expression of HPCAL4 mRNA

NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HPS1 mRNA

NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268

G

HPS4, biogenesis of lysosomal organelles complex 3 subunit 2

increases expression

benzo(b)fluoranthene results in increased expression of HPS4 mRNA

NCBI chr12:44,264,037...44,294,791
Ensembl chr12:44,264,037...44,294,632

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HSD11B1 mRNA

NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687

G

hydroxysteroid (17-beta) dehydrogenase 6

increases expression

benzo(b)fluoranthene results in increased expression of HSD17B6 mRNA

NCBI chr 7:422,466...442,008
Ensembl chr 7:422,480...442,425

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7

increases expression

benzo(b)fluoranthene results in increased expression of HSD3B7 mRNA

NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442

G

heat shock protein 90 alpha family class A member 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HSP90AA1 mRNA

NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268

G

heat shock protein 90 beta family member 1

increases expression

benzo(b)fluoranthene results in increased expression of HSP90B1 mRNA

NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788

G

heat shock protein family A (Hsp70) member 1A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HSPA1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HSPA1A mRNA

PMID:26377693 PMID:27858113

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

HIV-1 Tat interactive protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HTATIP2 mRNA

NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629

G

HIV-1 Tat specific factor 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HTATSF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HTATSF1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607

G

5-hydroxytryptamine receptor 2A

increases expression

benzo(b)fluoranthene results in increased expression of HTR2A mRNA

NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928

G

hormonally upregulated Neu-associated kinase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of HUNK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA

PMID:26377693 PMID:27858113

NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526

G

hyccin PI4KA lipid kinase complex subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of HYCC2 mRNA

NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007

G

islet cell autoantigen 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ICA1 mRNA

NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298

G

inhibitor of DNA binding 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ID1 mRNA
benzo(b)fluoranthene results in increased expression of ID1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ID1 mRNA

PMID:18711122 PMID:26377693 PMID:27858113

NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419

G

inhibitor of DNA binding 2

increases expression

benzo(b)fluoranthene results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

immediate early response 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of IER5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IER5 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227

G

interferon-induced protein 44

decreases expression

benzo(b)fluoranthene results in decreased expression of IFI44 mRNA

NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844

G

insulin-like growth factor 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGF1 mRNA
benzo(b)fluoranthene results in increased expression of IGF1 mRNA

PMID:16269432 PMID:17690111

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 2

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGF2 mRNA

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor 2 receptor

increases expression

benzo(b)fluoranthene results in increased expression of IGF2R mRNA

NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501

G

insulin-like growth factor binding protein 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA
benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA

PMID:16269432 PMID:17690111

NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 2

increases expression

benzo(b)fluoranthene results in increased expression of IGFBP2 mRNA

NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937

G

insulin-like growth factor binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP3 mRNA

NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083

G

insulin-like growth factor binding protein 4

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP4 mRNA

NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225

G

insulin-like growth factor binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP6 mRNA

NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966

G

IGF-like family receptor 1

increases expression

benzo(b)fluoranthene results in increased expression of IGFLR1 mRNA

NCBI chr 1:85,818,428...85,821,032
Ensembl chr 1:85,816,326...85,821,030

G

immunoglobulin superfamily, member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA

NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645

G

Indian hedgehog signaling molecule

increases expression

benzo(b)fluoranthene results in increased expression of IHH mRNA

NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532

G

IKAROS family zinc finger 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of IKZF4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341

G

interleukin 18 receptor 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of IL18R1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IL18R1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715

G

interleukin 1 beta

increases expression

benzo(b)fluoranthene results in increased expression of IL1B mRNA

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 1 receptor type 2

increases expression

benzo(b)fluoranthene results in increased expression of IL1R2 mRNA

NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725

G

interleukin 1 receptor-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of IL1RL1 mRNA

NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256

G

interleukin 2 receptor subunit beta

decreases expression

benzo(b)fluoranthene results in decreased expression of IL2RB mRNA

NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054

G

interleukin 6

increases secretion
increases expression

benzo(b)fluoranthene results in increased secretion of IL6 protein
benzo(b)fluoranthene results in increased expression of IL6 mRNA

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

interleukin 7 receptor

increases expression

benzo(b)fluoranthene results in increased expression of IL7R mRNA

NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757

G

interleukin enhancer binding factor 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA

NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337

G

inflammation and lipid regulator with UBA-like and NBR1-like domains

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILRUN mRNA

NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,809,936...5,876,012

G

inner mitochondrial membrane peptidase subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of IMMP2L mRNA

NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840

G

inner centromere protein

increases expression

benzo(b)fluoranthene results in increased expression of INCENP mRNA

NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265

G

inverted formin 2

increases expression

benzo(b)fluoranthene results in increased expression of INF2 mRNA

NCBI chr 6:131,649,162...131,675,944
Ensembl chr 6:131,649,211...131,675,941

G

inka box actin regulator 2

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA
benzo(b)fluoranthene results in increased expression of INKA2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642

G

INO80 complex subunit B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of INO80B mRNA

NCBI chr 4:115,627,907...115,631,069
Ensembl chr 4:115,627,908...115,631,456

G

inositol polyphosphate-5-phosphatase J

decreases expression

benzo(b)fluoranthene results in decreased expression of INPP5J mRNA

NCBI chr14:78,374,161...78,385,305
Ensembl chr14:78,374,161...78,385,326

G

IQ motif containing GTPase activating protein 3

increases expression

benzo(b)fluoranthene results in increased expression of IQGAP3 mRNA

NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956

G

inositol 1,4,5-triphosphate receptor associated 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of IRAG2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IRAG2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:178,088,902...178,143,569
Ensembl chr 4:178,088,507...178,143,557

G

interferon regulatory factor 2 binding protein 2

decreases expression

benzo(b)fluoranthene results in decreased expression of IRF2BP2 mRNA

NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642

G

interferon regulatory factor 2 binding protein-like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IRF2BPL mRNA

NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:106,528,053...106,530,401

G

interferon regulatory factor 5

increases expression

benzo(b)fluoranthene results in increased expression of IRF5 mRNA

NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267

G

interferon regulatory factor 7

decreases expression

benzo(b)fluoranthene results in decreased expression of IRF7 mRNA

NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832

G

integrin subunit alpha 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA1 mRNA

NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238

G

integrin subunit alpha 6

decreases expression

benzo(b)fluoranthene results in decreased expression of ITGA6 mRNA

NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428

G

integrin subunit alpha 7

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA7 mRNA

NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450

G

integrin subunit beta 4

increases expression

benzo(b)fluoranthene results in increased expression of ITGB4 mRNA

NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012

G

influenza virus NS1A binding protein

decreases expression

benzo(b)fluoranthene results in decreased expression of IVNS1ABP mRNA

NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701

G